Several new treatments for multiple sclerosis have been successfully developed over the last decade. Each of these drugs has had to undergo extensive investigation before obtaining approval for general use.
The testing of new multiple sclerosis therapies is typically done in large clinical trials and is often the culmination of many years of prior laboratory-based research and development. Occasionally, the MS clinic at Johns Hopkins will offer patients the opportunity to participate in clinical trials that are designed to test the effectiveness of new forms of therapy. Clinical trials are voluntary, and our team will only involve patients who are entirely comfortable with the process.
All clinical trials conducted here at Johns Hopkins are approved and closely monitored by the University’s Institutional Review Board. None of our MS clinic faculty have any financial interests or holdings in the various pharmaceutical companies who produce drugs used to treat MS.
If you would like study information or to participate in trials, please contact:
Karen DeBusk, RN
Research Program Coordinator
410.614.4823 voice
410.502.6736 fax
kdebusk@jhmi.edu
Clinical Trials
A Woman's Journey Saturday, November 14, 2009
Douglas Kerr will speak about Autoimmune Diseases at Johns Hopkins Medicine's annual women’s health conference,
A Woman’s Journey,
Click here for more information>>
Please donate to support Dr. Peter Calabresi on his Mt. Adams climb to help fund MS Research at Hopkins. 
Remote Second Opinion Have you been diagnosed with a neurological infectious disease and have an interest in obtaining a second opinion? Consider the Johns Hopkins Neuroimmunology and Neurological Infections Remote Second Opinion Program.
Click here for details
The Molly O. Kunkel Nursing Fund
Molly Kunkel, registered nurse and member of Transverse Myelitis Center, passed away from cancer in September 2007. For further details about the fund and how to make a contribution,
please click here>>
Follow this link to purchase greeting cards in support of MS research at Johns Hopkins Project RESTORE.
Every hour of every day, someone is newly diagnosed with MS
Hear how Johns Hopkins and others are striving to create therapies that protect and rebuild the Central Nervous System.
Click here >>
